title: Inhibition of enveloped viruses infectivity by curcumin.
abstract: Curcumin, a natural compound and ingredient in curry, has antiinflammatory, antioxidant, and anticarcinogenic properties. Previously, we reported that curcumin abrogated influenza virus infectivity by inhibiting hemagglutination (HA) activity. This study demonstrates a novel mechanism by which curcumin inhibits the infectivity of enveloped viruses. In all analyzed enveloped viruses, including the influenza virus, curcumin inhibited plaque formation. In contrast, the nonenveloped enterovirus 71 remained unaffected by curcumin treatment. We evaluated the effects of curcumin on the membrane structure using fluorescent dye (sulforhodamine B; SRB)-containing liposomes that mimic the viral envelope. Curcumin treatment induced the leakage of SRB from these liposomes and the addition of the influenza virus reduced the leakage, indicating that curcumin disrupts the integrity of the membranes of viral envelopes and of liposomes. When testing liposomes of various diameters, we detected higher levels of SRB leakage from the smaller-sized liposomes than from the larger liposomes. Interestingly, the curcumin concentration required to reduce plaque formation was lower for the influenza virus (approximately 100 nm in diameter) than for the pseudorabies virus (approximately 180 nm) and the vaccinia virus (roughly 335 × 200 × 200 nm). These data provide insights on the molecular antiviral mechanisms of curcumin and its potential use as an antiviral agent for enveloped viruses.
authors: Department of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan.
authors: Tzu-Yen
authors: TY
authors: Chen
authors: Da-Yuan
authors: DY
authors: Chen
authors: Hsiao-Wei
authors: HW
authors: Wen
authors: Jun-Lin
authors: JL
authors: Ou
authors: Shyan-Song
authors: SS
authors: Chiou
authors: Jo-Mei
authors: JM
authors: Chen
authors: Min-Liang
authors: ML
authors: Wong
authors: Wei-Li
authors: WL
authors: Hsu
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D002642:Chick Embryo; D002522:Chlorocebus aethiops; D003474:Curcumin / Q000737:chemistry / Q000494:pharmacology*; D003716:Dengue Virus / Q000187:drug effects; D004285:Dogs; D004664:Encephalitis Virus, Japanese / Q000187:drug effects; D029821:Enterovirus A, Human / Q000187:drug effects; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects*; D008081:Liposomes / Q000737:chemistry; D061985:Madin Darby Canine Kidney Cells; D009522:Newcastle disease virus / Q000187:drug effects*; D014162:Transfection; D014709:Vero Cells; D010948:Viral Plaque Assay; D053586:Virus Internalization / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D008081:Liposomes; D003474:Curcumin
references: J Pharm Pharmacol. 1997 Jan;49(1):105-7
references: 9120760
references: FEBS Lett. 2010 Jun 3;584(11):2485-90
references: 20434445
references: Biochem Pharmacol. 2003 Feb 1;65(3):361-76
references: 12527329
references: Life Sci. 2006 Mar 27;78(18):2081-7
references: 16413584
references: Biochem Pharmacol. 1995 Apr 18;49(8):1165-70
references: 7748198
references: Exp Cell Res. 1998 Dec 15;245(2):303-12
references: 9851871
references: Ann N Y Acad Sci. 2005 Nov;1056:206-17
references: 16387689
references: J Biol Chem. 2004 Mar 19;279(12):11680-5
references: 14701837
references: Biochemistry. 2007 Sep 11;46(36):10384-91
references: 17705403
references: J Cell Biochem. 2003 May 1;89(1):1-5
references: 12682902
references: J Gen Virol. 2004 Aug;85(Pt 8):2347-2356
references: 15269376
references: J Neuroimmune Pharmacol. 2009 Sep;4(3):328-37
references: 19434500
references: Anal Bioanal Chem. 2005 Jul;382(5):1217-26
references: 15977030
references: Biochem Pharmacol. 1990 Jun 15;39(12):1869-75
references: 2353930
references: Am J Pathol. 2003 Sep;163(3):1167-75
references: 12937158
references: Bioorg Med Chem. 1993 Dec;1(6):415-22
references: 8087563
references: Cell Microbiol. 2007 Jul;9(7):1683-94
references: 17324159
references: Oncogene. 2006 Jan 12;25(2):278-87
references: 16170359
references: Biochem Pharmacol. 1979 Mar 1;28(5):613-20
references: 444248
references: Mol Pharm. 2007 Nov-Dec;4(6):807-18
references: 17999464
references: J Virol. 2007 Apr;81(7):3142-50
references: 17229707
references: Biochem Biophys Res Commun. 1995 Jan 17;206(2):533-40
references: 7530002
references: FEBS Lett. 1998 Aug 21;433(3):287-93
references: 9744813
references: Virology. 2008 Apr 10;373(2):239-47
references: 18191976
references: Bioorg Med Chem Lett. 2005 Jul 15;15(14):3364-8
references: 15950462
references: FEBS Lett. 2010 Feb 19;584(4):707-12
references: 20026048
references: Biochem Pharmacol. 2002 Aug 15;64(4):573-82
references: 12167476
references: Blood. 2003 Feb 1;101(3):1053-62
references: 12393461
references: Biochem Pharmacol. 2008 Feb 15;75(4):787-809
references: 17900536